Quarterly ResultAug 5, 2026, 04:24 PM
MYOMO Q2 Revenue $11.70M, Net Loss $(4.02M), EPS $(0.09)
AI Summary
MYOMO, INC. reported a revenue increase for the second quarter of 2026 to $11.70 million, up from $9.65 million year-over-year, and a reduced net loss of $(4.02) million compared to $(4.63) million in the prior year. Diluted EPS improved to $(0.09) from $(0.11) year-over-year. The company also significantly decreased cash used in operating activities for the first six months of 2026 to $(4.14) million from $(11.54) million in the same period last year, and stated it has sufficient liquidity to fund operations for at least the next twelve months.
Key Highlights
- Revenue for Q2 2026 increased to $11.70M from $9.65M YoY.
- Net loss for Q2 2026 was $(4.02M) compared to $(4.63M) YoY.
- Diluted EPS for Q2 2026 was $(0.09) vs $(0.11) YoY.
- Cash, cash equivalents, and short-term investments totaled $13.45M as of June 30, 2026.
- Cash used in operating activities for H1 2026 decreased to $(4.14M) from $(11.54M) YoY.
- Direct to patient revenue for H1 2026 was $15.34M, up from $15.23M YoY.
- Clinical/Medical providers revenue for H1 2026 was $6.47M, up from $4.26M YoY.
- Company believes current cash will fund operations for at least the next 12 months.
Price Impact
More from MYO